The EASD Rising Star Symposium and EFSD Rising Star Fellowship Programme aims to identify promising and innovative young researchers who are developing their research activities in Europe. Selected candidates will have the opportunity to present an overview of their past and ongoing research activities during a multidisciplinary research symposium at the EASD Annual Meeting. The chosen candidates will be invited by EASD to present a lecture (20-minute lecture + 5-minute discussion) and will receive a commemorative diploma. Travel expenses, hotel and registration costs for the recipients will be covered.
Furthermore, the award includes a research fellowship in the amount of Euro 30,000 payable to the recipient’s institution. The objective of the research fellowship is to encourage innovative research in the field of diabetes. Applicants should have demonstrated their ability in the field of diabetes research and must be employed by a non-profit institution based in Europe or an associated country (for detailed country list, please see here).
Fellowship Applications
Applications can be submitted by early career scientists: scientists and clinicians at an early stage of their career, up to 7 years since completion of their most recent degree (PhD, MSc, or MD degrees). Eligibility can be extended for reasons such as maternity, paternity, illness, national service, clinical training, natural disasters, or asylum, if clearly described (further documentation may be requested at the discretion of EASD/EFSD). The time since the last degree may not exceed seven years before 1 January in the year the Fellowship is awarded.
Applicants must be a paid up member of EASD.
Preference will be given to individuals who have consistently pursued a well-defined and innovative research line, leading to publications in high impact peer reviewed journals.
Required documents include:
Applications for this programme must be submitted in the EFSD programme portal. Follow the step-by-step instructions in the User Guide to complete and submit your application. Access the portal:
All applications must be prepared on the official application form in the EFSD programme portal and completed in strict accordance with the detailed instructions to be found there. Applications which do not comply with the instructions given in the application system will not be considered for review.
Please submit your application in the EFSD programme portal before 12:00 midday (CET) on the deadline date 17 February 2026.
Note: For this particular award, it is permissible to hold a second active award from EFSD. Completed applications will be evaluated by an independent scientific committee.
Schedule
Announcement: November 2025
Application Deadline: 17 February 2026
Anticipated Award: May 2026
EFSD awards are peer reviewed by panels of international diabetes research experts, and competitive applications tend to share these strong predictors of success:
🔹 1. Clear Relevance to Diabetes Biology, Treatment or Complications
Proposals must focus on advancing fundamental understanding or clinical management of diabetes or related conditions, including mechanisms of disease, prevention, therapy, care delivery, or monitoring. europeandiabetesfoundation.org
Success tactic:
Frame projects around clear diabetes-specific questions and show how the results will move the field forward.
🔹 2. Scientific Innovation & Originality
EFSD reviewers look for novel hypotheses, innovative methods, or unique conceptual frameworks that extend beyond incremental research. Trialect
Success tactic:
Emphasise what makes your approach new and why this could change understanding or practice.
🔹 3. Rigorous Methodological Design & Feasibility
Strong study design — including appropriate statistical plans, well-defined outcomes, and feasible timelines within the requested funding period — is critical for credibility and score. Trialect
Success tactic:
Include clear workplans, milestones, and data analysis strategies that reviewers can assess easily.
🔹 4. Investigator Track Record & Institutional Support
Especially for Future Leaders and Young Investigator awards, panels weigh the candidate’s publication record, prior funding, leadership potential, and institutional backing. Novo Nordisk Fonden
Success tactic:
Document your diabetes research contributions and show evidence of supportive infrastructure or mentorship.
🔹 5. Alignment with Programme Goals
Each scheme has specific aims — e.g., long-term leadership for Future Leaders vs early research momentum for Rising Star or project relevance for basic/clinical grants. europeandiabetesfoundation.org
Success tactic:
Tailor applications to the particular objectives and eligibility criteria of the award you’re applying to.
🔹 6. Clarity & Quality of Proposal Writing
Clear, logically structured narratives that highlight significance, innovation, feasibility, and impact are easier for reviewers to score highly. Trialect
Success tactic:
Use straightforward language, defined aims, and a concise impact statement that connects to broader diabetes challenges.
🔹 7. Demonstrated Impact or Translation Plan
For clinical and translational grants, showing a credible path to impact — how findings will be used in practice or influence future research — strengthens competitiveness. europeandiabetesfoundation.org
Success tactic:
Articulate the potential for clinical application or translational uptake where applicable.
✔ Check eligibility and deadlines early — EFSD offers multiple programmes with varying requirements; the annual calendar (e.g., Feb/March deadlines) is published online. europeandiabetesfoundation.org
✔ Engage mentors and institutional support — strong letters and institutional commitment help for career awards.
✔ Connect to EASD membership where required (some awards require EASD membership). Novo Nordisk Fonden
✔ Align with strategic priorities — tailor aims to match EFSD calls (e.g., type 1 vs type 2 vs digital health themes).
✔ Use past funded projects as benchmarks — review recipients to understand typical scope and quality. europeandiabetesfoundation.org
| Predictor | Why It Matters |
|---|---|
| Diabetes relevance | Core mission of EFSD. europeandiabetesfoundation.org |
| Innovation & originality | Distinguishes proposals. Trialect |
| Methodological rigor | Ensures feasibility. Trialect |
| Investigator strength | Especially for career awards. Novo Nordisk Fonden |
| Programme alignment | Must fit specific award goals. europeandiabetesfoundation.org |
| Clarity & writing quality | Improves reviewer scoring. Trialect |
| Impact/translation | Enhances relevance for clinical grants. |
Applications can be submitted by early career scientists: scientists and clinicians at an early stage of their career, up to 7 years since completion of their most recent degree (PhD, MSc, or MD degrees). Eligibility can be extended for reasons such as maternity, paternity, illness, national service, clinical training, natural disasters, or asylum, if clearly described (further documentation may be requested at the discretion of EASD/EFSD).
Sponsor Institute/Organizations: European Foundation for the Study of Diabetes
Sponsor Type: Corporate/Non-Profit
Address: Rheindorfer Weg 3 40591 Düsseldorf
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Feb 17, 2026
Feb 17, 2026
$35,142
Affiliation: European Foundation for the Study of Diabetes
Address: Rheindorfer Weg 3 40591 Düsseldorf
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.